Updated Microbot Medical (NASDAQ: MBOT) investor deck and conference talk

Rhea-AI Filing Summary

Microbot Medical Inc. furnished an update under Regulation FD by making new investor presentation materials available on its website. The slides can be accessed through the ‘Investors’ section under ‘IR Resources’ and then ‘Additional Resources.’

The company also highlighted its participation in the H.C. Wainwright Annual Investor Conference in New York, where President, CEO and Chairman Harel Gadot is scheduled to present on September 9, 2025, with a live webcast available through the ‘Events’ section of the website. The presentation materials are furnished as Exhibit 99.1 to this report and are expressly described as furnished, not filed, which limits their treatment under certain securities law liability provisions.

8-K Event Classification

2 items: 7.01, 9.01

2 items

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Understanding 8-K Material Events →

false 0000883975 0000883975 2025-09-09 2025-09-09 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 9, 2025

MICROBOT MEDICAL INC.

(Exact name of registrant as specified in its charter)

Delaware		000-19871		94-3078125
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

175 Derby St., Bld. 27

Hingham, MA 02043

(Address of Principal Executive Offices) (Zip Code)

Registrant’s telephone number, including area code: (781) 875-3605

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.01 par value		MBOT		NASDAQ Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging Growth Company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01 Regulation FD Disclosure.

On September 9, 2025, Microbot Medical Inc. (the “Company”) released updated presentation materials. The presentation materials may be accessed via the ‘Investors’ section, under ‘IR Resources’ and then ‘Additional Resources,’ of the Company’s website at www.microbotmedical.com. The Company is not undertaking to update these presentation materials.

As previously announced, the Company is attending the H.C. Wainwright Annual Investor Conference held in New York, New York, from September 8-10, 2025. Mr. Harel Gadot, the Company’s President, CEO and Chairman, will present live on Tuesday, September 9, 2025 at 9:00 am ET, and a live webcast may be accessed via the ‘Events’ section of the Company’s website at www.microbotmedical.com.

The presentation materials are also furnished as Exhibit 99.1 to this Current Report on Form 8-K, and are incorporated herein by reference. The information in this Item 7.01 and Exhibit 99.1 is being furnished and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. This report will not be deemed an admission as to the materiality of any information in this Item 7.01 or Exhibit 99.1.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit Number		Description
99.1		Presentation Materials
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	MICROBOT MEDICAL INC.
	By:	/s/ Harel Gadot
	Name:	Harel Gadot
	Title:	Chief Executive Officer, President and Chairman

Date: September 9, 2025

FAQ

What did Microbot Medical Inc. (MBOT) disclose in this 8-K?

Microbot Medical Inc. disclosed that it released updated investor presentation materials and furnished them as Exhibit 99.1, with access provided through its website.

Where can investors find Microbot Medical (MBOT) presentation materials?

Investors can access the updated presentation materials via the ‘Investors’ > ‘IR Resources’ > ‘Additional Resources’ sections of the company’s website at www.microbotmedical.com.

Is the Microbot Medical (MBOT) investor presentation considered filed with the SEC?

The company states that the information in Item 7.01 and Exhibit 99.1 is being furnished and shall not be deemed to be filed for purposes of Section 18 of the Exchange Act.

What event is Microbot Medical (MBOT) attending according to this 8-K?

Microbot Medical is attending the H.C. Wainwright Annual Investor Conference in New York, New York, held from September 8–10, 2025.

When is Microbot Medical’s management presenting at the H.C. Wainwright conference?

President, CEO and Chairman Harel Gadot is scheduled to present live on Tuesday, September 9, 2025 at 9:00 a.m. ET, with a webcast available via the website’s ‘Events’ section.

Which exhibits are included in this Microbot Medical (MBOT) 8-K?

The report lists Exhibit 99.1 as Presentation Materials and Exhibit 104 as the Cover Page Interactive Data File embedded within the Inline XBRL document.